OLIPOP PBC Secures $93.5M Series C Funding to Expand Accessible Digestive Health Solutions

OLIPOP PBC is excited to announce that we have successfully raised $93,500,000 to fuel the next phase of our growth and innovation in the health beverage market. Founded in 2017 by Ben Goodwin and David Lester, OLIPOP has always been about more than just a refreshing drink—it’s about revolutionizing the way we think about digestive health. With nearly a decade of collaboration between our founders, our team has become passionate about making digestive wellness accessible to everyone. This substantial funding round is a testament to the confidence our investors have in our unique approach that blends prebiotics, botanicals, and natural plant fiber to support a healthy microbiome, while delivering an affordable and delicious alternative to traditional soda. With this capital injection, OLIPOP is set to accelerate our mission to offer a vibrant, community-focused option for those seeking healthier beverage choices. The funds will be strategically invested in broadening our market reach, scaling our production capabilities, and enhancing our research and development efforts to continue innovating within the functional drink category. We remain committed to celebrating diversity—in our products, our microbiome, and our communities—and ensuring that premium gut health benefits are available to mainstream consumers. Our passionate and diverse team, driven by a high-performance culture and a growth mindset, is ready to take on ambitious projects that will redefine the beverage landscape. Stay tuned for more updates as we continue on this exciting journey, and remember to verify any communication using our official @drinkolipop.com email address before responding.